J&J links up with Foundation Medicine for cancer genomic test

Foundation Medicine, a provider of cancer genomic tests and online test data access, has inked a collaboration pact with Johnson & Johnson's ($JNJ) pharma R&D unit to find biomarkers with its test to aid the J&J group's development of cancer drugs. J&J is the fourth pharma to sign up for Foundation's cancer genomic test, which uses next-generation sequencing tech. The company's website also links test data to sources of publicly available information, and its plans include using its website to match patients with appropriate cancer drug trials. Release

Suggested Articles

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.